The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

 
Web www.patentalert.com

< Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

> Compounds for the treatment of hepatitis C

> Chemokine receptor antagonists and methods of use therefor
~ 00522